Greenlane (GNLN) Stock Price, News & Analysis

1 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Greenlane in the last year. There are currently 1 hold rating for the stock. The consensus among Wall Street research analysts is that investors should "hold" GNLN shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in GNLN, but not buy additional shares or sell existing shares.
View GNLN analyst ratings or view top-rated stocks.

Greenlane's stock was trading at $0.5180 at the beginning of the year. Since then, GNLN shares have increased by 4.2% and is now trading at $0.5397.
View the best growth stocks for 2024 here.

Greenlane saw a increase in short interest in April. As of April 15th, there was short interest totaling 70,300 shares, an increase of 557.0% from the March 31st total of 10,700 shares. Based on an average daily trading volume, of 333,000 shares, the short-interest ratio is presently 0.2 days. Currently, 1.9% of the shares of the stock are sold short.
View Greenlane's Short Interest.

The company is scheduled to release its next quarterly earnings announcement on Monday, May 20th 2024.
View our GNLN earnings forecast.

Greenlane Holdings, Inc. (NASDAQ:GNLN) released its earnings results on Monday, November, 15th. The company reported ($46.00) earnings per share for the quarter, missing analysts' consensus estimates of ($14.00) by $32.00. The business earned $41.31 million during the quarter, compared to the consensus estimate of $40.31 million. Greenlane had a negative trailing twelve-month return on equity of 80.94% and a negative net margin of 57.00%. During the same quarter last year, the business posted ($92.00) earnings per share.

AXS Cannabis ETF holds 63,837 shares of GNLN stock, representing 0.42% of its portfolio.

Greenlane shares reverse split on the morning of Tuesday, June 6th 2023. The 1-10 reverse split was announced on Tuesday, June 6th 2023. The number of shares owned by shareholders was adjusted after the closing bell on Tuesday, June 6th 2023. An investor that had 100 shares of stock prior to the reverse split would have 10 shares after the split.

Based on aggregate information from My MarketBeat watchlists, some companies that other Greenlane investors own include KushCo (KSHB), Organigram (OGI), Enerplus (ERF), Matinas BioPharma (MTNB), Supreme Cannabis (SPRWF), ADMA Biologics (ADMA), EnLink Midstream (ENLC), Gran Tierra Energy (GTE), MariMed (MRMD) and Novan (NOVN).

Greenlane (GNLN) raised $80 million in an initial public offering on Thursday, April 18th 2019. The company issued 5,300,000 shares at a price of $14.00-$16.00 per share. Cowen and Company and Canaccord Genuity served as the underwriters for the IPO and Ladenburg Thalmann, Roth Capital Partners and Northland Securities were co-managers.

Shares of GNLN stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.